Organon Missed Consensus Estimates

Organon (OGN) reported earnings of $0.88 per share on revenue of $1.57 billion for the third quarter ended September 2026. The consensus earnings estimate was $0.95 per share on revenue of $1.57 billion. The company missed consensus estimates by 7.37% while revenue fell 1.75% compared to the same quarter a year ago.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.